Whole-Genome Sequencing for Surveillance of AMR in
Foodborne Bacterial PathogensErrol Strain
Senior Advisor for Science InformaticsNational Antimicrobial Resistance Monitoring System (NARMS)
FDA Center for Veterinary Medicine
CASSS Meeting 2/20/2022
2
DisclaimerThe views expressed in this presentation are the thoughts and opinions of the author and do not represent the views or policies of the FDA. Center for Veterinary Medicine
• Office of Research, Laurel MD• Changes in the antimicrobial
susceptibility of enteric (intestinal) bacteria – food, animals, humans
• Track & limit spread of resistance
3
Overview1. What is NARMS2. Whole-Genome Sequencing (WGS) and
Food Safety3. Genotype = Phenotype4. NCBI Pathogen Detection
1. What is NARMS?
5
The Review on Antimicrobial Resistance Chaired by Jim
O’Neill December 2014
Global Burden of rise in
Antimicrobial Resistance
(AMR) – 2.5-3% reduction in
GDP by 2050
FDA\NARMS – Monitor burden of
resistance from food animals
6
• NARMS is a collaborative program of state and local public health departments and universities, the FDA, the Centers for Disease Control and Prevention (CDC), and the U.S. Department of Agriculture (USDA).
• This national public health surveillance system tracks changes in the antimicrobial susceptibility of enteric (intestinal) bacteria found in ill people (CDC), retail meats (FDA), and food animals (USDA) in the United States.
• The NARMS program helps promote and protect public health by providing information about emerging bacterial resistance, how resistant infections differ from susceptible infections, and the impact of interventions designed to limit the spread of resistance.
• NARMS data are used by FDA to make regulatory decisions designed to preserve the effectiveness of antibiotics for humans and animals.
Random stratified sampling in 21 States
ORA Imported Foods
Random cecal samplingof national production
at slaughter
Eastern FSIS Laboratory
Animal PopulationRetail Meats
21 States Labs
Human Population
Physician Visit
Local Lab
State Lab
Campylobacter
Salmonella
Enterococcus
E. coli
HACCP isolates
FSIS
Data Integration
Integrated Report
(E. coli O157:H7, S. Typhi, Shigella, Vibrio)
Integrated Surveillance of Antimicrobial Resistance in Foodborne Bacteria:1996
ChickenTurkeyPorkBeef
8
• Cover all 4 U.S census regions: W,
MW, NE and S;• Collect samples in
area that represent 22.67% of the US
population;• Test samples from
states that encompass 58.44%
of the U.S population;
State Public Health Departments and Universities2002 CT, GA, MD, MN, TN, OR 2003 CT, GA, MD, MN, TN, OR, NY, CA 2004 CT, GA, MD, MN, TN, OR, NY, CA, CO, NM2008 CT, GA, MD, MN, TN, OR, NY, CA, CO, NM, PA2012 CT, GA, MD, MN, TN, OR, NY, CA, CO, NM, PA, WA, LA, MO,2017 CT, GA, MD, MN, TN, OR, NY, CA, CO, NM, PA, WA, LA, MO, IA, SC, KS, ND/SD, TX/OK, NC2020 CT, GA, MD, MN, TN, OR, NY, CA, CO, NM, PA, WA, LA, MO, IA, SC, KS, ND/SD, TX/OK, OH, HI
Retail Meat Sampling
9
NARMS Panels (2018)
Salmonella Campylobacter E. coli EnterococcusAmoxicillin-Clavulanic Acid X XAmpicillin X XAzithromycin X X XCefoxitin X XCeftiofur X XCeftriaxone X XChloramphenicol X X X XCiprofloxacin X X X XClindamycin XDaptomycin XErythomycin X XFlavovmycin XFlorenicol XGentamicin X X X XKanamycin XLincomycin XLinezolid XMeropenem X X XNalidixic Acid X X XNitrofurantoin XPenicillin XStreptomycin X X XSulfamethoxazole-Sufisoxazole X XTelithromycin XTetratracycline X X X XTigecycline XTrimethoprim-Sulfamethoxazole X XTylosin XVancomycin X
10
Veterinary Laboratory Investigation and
Response Network (Vet-LIRN)
• 2017-2018 pilot to evaluate the feasibility of using Vet-LIRN
veterinary diagnostic laboratories to monitor the
antimicrobial susceptibility of three veterinary pathogens:
Escherichia coli and Staphylococcus pseudintermedius in dogs
and Salmonella enterica in any host. Approximately 5,000
isolates from clinically sick animals were collected and tested
• Twenty Vet-LIRN Source diagnostic laboratories collected
isolates and tested the susceptibility using Clinical and
Laboratory Standards Institute (CLSI) methods. Additional
information about the pathogen (the organ it came from, the
animal species, which part of the country) was reported.
11
Pettengill JB, et al. Distribution of antimicrobial resistance genes across Salmonella enterica isolates from animal and non-animal foods. Submitted.
2. WGS and Food Safety
13
Why Develop a WGS based Network?
Tracking and Tracing of food pathogens• Insufficient resolution of current tools
-matching clinical to environmental-improve the environmental database
• Faster identification of the food involved in the outbreak
• Limited number of investigators vs. facilities and import lines
• Global travel• Global food supply
14
Farm/Supplier Processing Facility/ Distributor
Food/Feed Patient
Laboratory
WGS and Food Safety
Microbiology Laboratory Workflow
GenomeTrakr Labs& Collaborators
Salmonella
Listeria
E.coli and Shigella, Campylobacter jejuni, Klebsiella pneumoniae, Mycobacterium tuberculosis, Acinetobacter baumannii, Neisseria, Pseudomonas aeruginosa, Enterobacter, Clostridioides difficile, Vibrio parahaemolyticus, Vibrio cholerae, Legionella pneumophila, Cronobacter, Serratia marcescens, Staphylococcus pseudintermedius, Klebsiella oxytoca, Citrobacter freundii, Vibrio vulnificus, Clostridium botulinum, Clostridium perfringens, Providencia alcalifaciens, Elizabethkingia anopheles, Morganella morganii, Photobacterium damselae, Corynebacterium striatum, Kluyvera intermedia
16
17
> 300K Foodborne Pathogens
3. Genotype = Phenotype
19
Genotype-Phenotype Correlation
Isolate N33849PS
Phenotypic susceptibility
NAL FIS CHL TET STR
Sequencing/genotyping GyrA (S83L) sul2 floR tetA strA/strB
20
Predicting Resistance from the Genome
Bacterium Gen/Phe correlation Reference
99.70% Zankari et al., 2013, J Antimicrob Chemother
99.00% McDermott et al., 2016, Antimicrob Agents Chemother
97.10% Stoesser et al., 2013, J Antimicrob Chemother
98.50% Tyson et al 2015., J Antimicrob Chemother
Campylobacter spp. 99.20% Zhao et al 2015., J Antimicrob Chemother
Staphylococcus aureus 98.80% Gordon et al 2014., J Antimicrob Chemother
Pneumococcus 98.00% Metcalf et al 2016, Clin Microbiol Infect
Enterobacteriaceae (B-lacs) 100.00% Shelburne et al, 2017 Clin Infect Dis
95.30% Phelan et al 2016. Genome Med
92.30% Walker et al 2015. Lancet Infect Dis
Salmonella enterica
Escherichia coli
Mycobacterium
21
Resistance Genes
21
Resistance Gene Antimicrobial Class Resistance Phenotypeaac(3)-Id, aac(3)-IId, aac(3)-IV, aac(3)-VI Aminoglycosides GentamicinaadB Aminoglycosides Gentamicin, Kanamycinaph(3')-la, aph(3')-II Aminoglycosides Kanamycinaph(4)-la Aminoglycosides Hygromycin BaadA, 1, 2, 5, 7, 12, 13, 24, aac(6')-lb, aph(6)-lc, aph(3')-
lb (strA), aph(6)-Id (strB)
Aminoglycosides Streptomycin
blaCMY-2, blaCTX-M-1, blaCTX-M-14b, blaSHV-2a, blaFOX-6 β-lactams Amoxicillin-clavulanic acid, Ampicillin, Ceftriaxone, Cefoxitin,Ceftiofur
blaCARB-2, blaHERA-3, blaLAP-1, blaOXA2, blaTEM-1 β-lactams Ampicillin
ble, blmS Bleomycinsul1, 2, 3 Folate Pathway Inhibitors Sulfisoxazoledfr5, 7, dfrA1,8, 12, 14, 15, 17. Folate Pathway Inhibitors Trimethoprim-SulfamethoxazolemphA Macrolides Azithromycinmel, mphB, mphE Macrolides ErythromycincatA1, cmlA, floR Phenicols Chloramphenicol
oqxA, oqxB
Phenicols,Olaquindox, Quinolones Olaquindox
qacH QAC Disinfectants, ethidium bromideqnrA, qnrB19, qnrS Quinolones Reduced susceptibility to NAL, CIPtetA, B, C, D, G, M, O, X Tetracyclines TetracyclinelinB Lincosamides Lincomycin
22
Correlation between Antimicrobial Resistance Phenotype and Genotype in Salmonella (n=640)
ANTIBIOTICPhenotype: Resistant Phenotype: Susceptible
Genotype: resistant
Genotype: susceptible
Genotype: resistant
Genotype: susceptible
Sensitivity Specificity
GENTAMICIN 99 6 5 530 94.3% 99.1%STREPTOMYCIN 257 3 35 345 98.8% 90.8%AMOXY/CLAV 114 2 0 524 98.3% 100.0%CEFOXITIN 93 2 21 524 97.9% 96.1%CEFTIOFUR 113 0 4 523 100.0% 99.2%CEFTRAXONE 116 0 1 523 100.0% 99.8%AMPICILLIN 241 1 1 397 99.6% 99.7%SULFA 244 1 0 395 99.6% 100.0%TRM/SULFA 19 3 0 618 86.4% 100.0%AZTREONAM 1 0 0 639 100.0% 100.0%CHLORAMPHENICOL 44 0 1 595 100.0% 99.8%CIPROFLOXACIN 4 0 0 636 100.0% 100.0%NALIDIXIC ACID 13 2 0 625 86.7% 100.0%TETRACYCLINE 349 0 0 291 100.0% 100.0%
Totals 1707 20 68 7164 98.8% 99.1%
A total of 65 unique resistance genes, plus two housekeeping genes mutations were identified;
23
• Used 5,278 NARMS isolates with phenotype/genotype data
• Susceptibility to 16 antibiotics
• The MIC prediction models have average accuracies between 95-96% within ± 1 two-fold dilution factor.
• The models are capable of predicting susceptible and
resistant MICs with no a priori information about the underlying gene content of the genomes.
• By using diverse genomes for training sets, MIC prediction models with accuracies >90% can be
generated with fewer than 500 genomes.
Using AI to Predict MICs in Salmonella
Nguyen, M. et al. Using machine learning to predict antimicrobial MICs and associated genomic features for nontyphoidal Salmonella.
J. Clin Microbiol. Volume 57(2), Jan 30., 2019 .
4. NCBI Pathogen Detection
25
Monitoring the Resistome: In nucleum veritatis
• WGS is replacing many long-standing laboratory methods
• Involves a single analytical workflow providing a common data set at lower costs
• Provides the highest practical resolution of individuating structural traits in an organism
• Theoretically, any phenotype can be inferred from the genotype
• Major impact on microbiology, epidemiology and public health surveillance
• Level of detail results in a stronger scientific foundation for risk analysis and regulatory decision making
Last accessed Feb 15, 2020
26
Pathogen: environmental/food/other sample from Listeria monocytogenes BioSample: SAMN02709234;Sample name: FDA00007620Organism Listeria monocytogenescellular organisms; Bacteria; Firmicutes; Bacilli;Bacillales; Listeriaceae; ListeriaPathogen: environmental/food/other; v.1.0strain FDA00007620host disease missinglatitude and longitude missingcollection date 3/26/2012isolate CFSAN003790geographic location Italyisolation source moliterno al tartufo
cheesecollected by FDAPFGE_SecondaryEnzyme_pattern GX6A12.0280PFGE_PrimaryEnzyme_pattern GX6A16.0085SubmissionFDA, Justin Payne; 2014-03-27ID: 2709234
Pathogen: clinical or host-associated samplefrom Salmonella enterica
BioSample: SAMN02927343; Sample name:/2013K-0563Organism Salmonella entericacellular organisms; Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; SalmonellaPathogen: clinical or host-associated; version 1.0strain 2013K-0563collected by CDCcollection date Missinggeographic location USAhost Missinghost disease Missingisolation source Missinglatitude and longitude Missing
SubmissionPulsenet, Eija Trees; 2014-07-18ID: 2927343
Food/environmental Submission Clinical Submission
Metadata
27
Standard Antibiogram
28
NCBI Pathogen Detection
29
NCBI Pathogen Detection & AMRFinderPlus
Clinical isolate within 3 nucleotide changes of food/environmental isolate AMR genotype
30
AST Phenotypes and AMR Genotypes
31
Recap• NCBI Pathogen Detection and AMRFinder Plus– https://www.ncbi.nlm.nih.gov/pathogens/
• FDA NARMS and Vet-LIRN– Retail Meats/Seafood and Companion Animals
• Public Data Sharing– Anyone can submit to NCBI SRA and Pathogen
Detection– Need for more AST data, only ~2% of Salmonella
Acknowledgements
• FDA• Center for Veterinary Medicine• Center for Food Safety and Applied Nutrition• Office of Regulatory Affairs
• National Institutes of Health• National Center for Biotechnology Information
• State Health and University Labs• Alaska• Arizona• California• Florida• Hawaii• Maryland• Minnesota• New Mexico• New York• South Dakota• Texas• Virginia• Washington
• USDA/FSIS and ARS
• CDC• Enteric Diseases Laboratory
• INEI-ANLIS “Carolos Malbran Institute,” Argentina
• Centre for Food Safety, University College Dublin, Ireland and Irish FSA
• Melbourne (FSA). Australia
• Public Health England, UK
• Institute for Food Safety and Health (IFSH)
• WHO and FAO
• Illumina
• Pac Bio
• Other independent collaborators
33
Questions/Discussion